Personalised Active Self-management of Sleep Apnea Program
Key facts
- Who runs it
- Hong Kong Metropolitan University
- Where
- Hong Kong, Hong KongSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 3 Aug 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 4-month Personalized and Adaptive Sleep Support program (PASS)
- Control group
- Record updated
- 6 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Aged 18 years and above
- Newly diagnosed with OSA (diagnosis made within the past year)
- Newly started or not yet started Positive Airway Pressure (PAP) treatment, with a treatment duration of less than 6 months
- Physically inactive (self-reported moderate physical activity per week of <150 minutes)
- Overweight (BMI≥23 kg/m2)
- Mentally, cognitively, and physically fit to join the trial as determined by the doctor in charge and responsible clinical investigators
- Able to speak, read, and write Chinese
- Willing to complete the questionnaires and assessments
- Has a smartphone
Who cannot take part
- Use of prescription drugs or clinically significant drugs affecting sleep
- Clinically significant psychiatric disorder
Where in Hong Kong
- Queen Mary HopsitalHong Kong, Hong KongContact: Agnes Yuen-Kwan Lai, PhDNo longer taking part
About the trial
What the trial wants to find out
This study is to assess the feasibility and acceptability of the PASS in patients with OSA. Second, the study examines its effectiveness in improving PAP uptake and adherence, self-efficacy in self-care, changes in health-related habits, and health outcomes. We also assess the facilitators and barriers to implementing the PASS.
Read full original descriptionShow less
This is a two-group pilot randomized controlled trial (n=60) with a 4-month follow-up. Subjects assigned to the intervention group will receive a 4-month Personalized and Adaptive Sleep Support (PASS) program, a digital platform-based intervention. The 4-month program incorporates: i) a 20-minute brief motivational interviewing session; ii) a digital platform where users can view personalized OSA health-related videos and information, track their adherence to prescribed treatments, log their daily activities and dietary intake, and set personal health goals; and iii) continuous personalized chat-based messaging and phone call support. Participants in the control group will receive a 4-month general hygiene program, including (i) a 20-minute session, (ii) messaging, and (iii) phone call support.
The feasibility and acceptability of the PASS will be evaluated via semi-structured interviews at the 4-month follow-up. Self-administered questionnaires will be used at baseline and 4 months, and objective assessment tools (such as sleep tests) will be used at baseline and at the 4-month follow-ups. PAP adherence data will be downloaded from PAP machines (if available) for all subjects in both groups at baseline and at month 4.
The 2 groups in the trial
- General Hygiene Control groupExisting treatment, for comparison
Participants will receive a 4-month general hygiene information.
Treatment: Control group
- PASS Intervention groupTreatment being tested
Subjects in this arm will receive a 4-month digital Personalized and Adaptive Sleep Support program (PASS).
Treatment: 4-month Personalized and Adaptive Sleep Support program (PASS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Personalised Active Self-management of Sleep Apnea Program (PASS) to Improve Positive Airway Pressure Treatment Uptake and Adherence: A Pilot Randomized Controlled Trial
- Record updated
- 6 August 2026